These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2314 related items for PubMed ID: 24374462

  • 1. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H.
    Cochrane Database Syst Rev; 2013 Dec 27; (12):CD008623. PubMed ID: 24374462
    [Abstract] [Full Text] [Related]

  • 2. Herbal medicines for fatty liver diseases.
    Liu ZL, Xie LZ, Zhu J, Li GQ, Grant SJ, Liu JP.
    Cochrane Database Syst Rev; 2013 Aug 24; (8):CD009059. PubMed ID: 23975682
    [Abstract] [Full Text] [Related]

  • 3. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
    Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD005166. PubMed ID: 17253544
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
    Lombardi R, Onali S, Thorburn D, Davidson BR, Gurusamy KS, Tsochatzis E.
    Cochrane Database Syst Rev; 2017 Mar 30; 3(3):CD011640. PubMed ID: 28358980
    [Abstract] [Full Text] [Related]

  • 5. Statins for the treatment of dementia.
    McGuinness B, O'Hare J, Craig D, Bullock R, Malouf R, Passmore P.
    Cochrane Database Syst Rev; 2010 Aug 04; (8):CD007514. PubMed ID: 20687089
    [Abstract] [Full Text] [Related]

  • 6. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
    Lewicki M, Ng I, Schneider AG.
    Cochrane Database Syst Rev; 2015 Mar 11; 2015(3):CD010480. PubMed ID: 25758322
    [Abstract] [Full Text] [Related]

  • 7. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C.
    Metabolism; 2017 Jun 11; 71():17-32. PubMed ID: 28521870
    [Abstract] [Full Text] [Related]

  • 8. The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease.
    Doumas M, Imprialos K, Dimakopoulou A, Stavropoulos K, Binas A, Athyros VG.
    Curr Pharm Des; 2018 Jun 11; 24(38):4587-4592. PubMed ID: 30652643
    [Abstract] [Full Text] [Related]

  • 9. Statins for multiple sclerosis.
    Wang J, Xiao Y, Luo M, Zhang X, Luo H.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008386. PubMed ID: 21154395
    [Abstract] [Full Text] [Related]

  • 10. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis.
    Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F.
    Cochrane Database Syst Rev; 2007 Jan 24; 2007(1):CD004996. PubMed ID: 17253535
    [Abstract] [Full Text] [Related]

  • 11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 24; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 12. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
    Athyros VG, Boutari C, Stavropoulos K, Anagnostis P, Imprialos KP, Doumas M, Karagiannis A.
    Curr Vasc Pharmacol; 2018 Sep 24; 16(3):246-253. PubMed ID: 28676019
    [Abstract] [Full Text] [Related]

  • 13. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).
    Smith DG, McBurney CR.
    Pharmacoeconomics; 2003 Sep 24; 21 Suppl 1():13-23. PubMed ID: 12648031
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
    Fatima K, Moeed A, Waqar E, Atif AR, Kamran A, Rizvi H, Suri NF, Haider H, Shuja SH, Khalid M, Minhas AMK.
    Clin Res Hepatol Gastroenterol; 2022 Apr 24; 46(4):101816. PubMed ID: 34607067
    [Abstract] [Full Text] [Related]

  • 15. Lipid-lowering agents for nephrotic syndrome.
    Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.
    Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265
    [Abstract] [Full Text] [Related]

  • 16. Statins for acute ischemic stroke.
    Squizzato A, Romualdi E, Dentali F, Ageno W.
    Cochrane Database Syst Rev; 2011 Aug 10; (8):CD007551. PubMed ID: 21833959
    [Abstract] [Full Text] [Related]

  • 17. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.
    Athyros VG, Mikhailidis DP, Didangelos TP, Giouleme OI, Liberopoulos EN, Karagiannis A, Kakafika AI, Tziomalos K, Burroughs AK, Elisaf MS.
    Curr Med Res Opin; 2006 May 10; 22(5):873-83. PubMed ID: 16709309
    [Abstract] [Full Text] [Related]

  • 18. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Raval AD, Hunter T, Stuckey B, Hart RJ.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD008565. PubMed ID: 21975784
    [Abstract] [Full Text] [Related]

  • 19. Bezafibrate for primary biliary cirrhosis.
    Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2012 Jan 18; 1(1):CD009145. PubMed ID: 22259000
    [Abstract] [Full Text] [Related]

  • 20. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z, Rahme E, Pilote L.
    Am Heart J; 2006 Feb 18; 151(2):273-81. PubMed ID: 16442888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 116.